Northwest Medical Isotopes, LLC, 24289 [2015-10127]

Download as PDF Federal Register / Vol. 80, No. 83 / Thursday, April 30, 2015 / Notices prospective award nominees. Additional survey areas may also include: • Applicant Mentoring • Mentor Training • State selection Committee • State selection Process • Applicant and State Finalist Notification and Recognition • In-kind contributions The survey will evaluate the impact SCs have on attracting prospective award nominees to PAEMST. This will be conducted as a Web-based survey. Estimate of Burden: Public reporting burden for this collection of information is estimated to average 30–40 minutes for State Coordinators. Respondents: Individuals. Estimated Number of Responses per Form: 120 Coordinators. Estimated Total Annual Burden on Respondents: 80 hours (120 Coordinators at 40 minutes per survey = 80 hours). Frequency of Response: One per application cycle. Comments: Comments are invited on (a) whether the proposed collection of information is necessary for the proper performance of the PAEMST functions, including whether the information shall have practical utility; (b) the accuracy of the NSF’s estimate of the burden of the proposed collection of information; (c) ways to enhance the quality, utility, and clarity of the information on respondents, including through the use of automated collection techniques or other forms of information technology; (d) ways to minimize the burden of the collection of information on those who are to respond, including through the use of appropriate automated, electronic, mechanical or other technological collection techniques or other forms of information technology. Dated: April 27, 2015. Suzanne H. Plimpton, Reports Clearance Officer, National Science Foundation. [FR Doc. 2015–10074 Filed 4–29–15; 8:45 am] BILLING CODE 7555–01–P NUCLEAR REGULATORY COMMISSION mstockstill on DSK4VPTVN1PROD with NOTICES [Proj–0803; NRC–2013–0235] Northwest Medical Isotopes, LLC Nuclear Regulatory Commission. ACTION: Construction permit application; receipt. AGENCY: The U.S. Nuclear Regulatory Commission (NRC) staff has received SUMMARY: VerDate Sep<11>2014 17:01 Apr 29, 2015 Jkt 235001 and is making available the first part of the application for a construction permit, submitted by Northwest Medical Isotopes, LLC (NWMI). NWMI proposes to build a medical radioisotope production facility located in Columbia, Missouri. DATES: April 30, 2015. ADDRESSES: Please refer to Docket ID NRC–2013–0235 when contacting the NRC about the availability of information regarding this document. You may obtain publicly-available information related to this document using any of the following methods: • Federal Rulemaking Web site: Go to https://www.regulations.gov and search for Docket ID NRC–2013–0235. Address questions about NRC dockets to Carol Gallagher; telephone: 301–415–3463; email: Carol.Gallagher@nrc.gov. For technical questions, contact the individual listed in the FOR FURTHER INFORMATION CONTACT section of this document. • NRC’s Agencywide Documents Access and Management System (ADAMS): You may obtain publiclyavailable documents online in the ADAMS Public Documents collection at https://www.nrc.gov/reading-rm/ adams.html. To begin the search, select ‘‘ADAMS Public Documents’’ and then select ‘‘Begin Web-based ADAMS Search.’’ For problems with ADAMS, please contact the NRC’s Public Document Room (PDR) reference staff at 1–800–397–4209, 301–415–4737, or by email to pdr.resource@nrc.gov. The ADAMS accession number for each document referenced (if it available in ADAMS) is provided the first time that a document is referenced. • NRC’s PDR: You may examine and purchase copies of public documents at the NRC’s PDR, Room O1–F21, One White Flint North, 11555 Rockville Pike, Rockville, Maryland 20852. FOR FURTHER INFORMATION CONTACT: Michael Balazik, Office of Nuclear Reactor Regulation, U.S. Nuclear Regulatory Commission, Washington, DC 20555–0001; telephone: 301–415– 2856; email: Michael.Balazik@nrc.gov. SUPPLEMENTARY INFORMATION: On November 7, 2014, NWMI filed with the NRC, pursuant to Section 103 of the Atomic Energy Act of 1954, as amended, and part 50 of Title 10 of the Code of Federal Regulations (10 CFR), a portion of an application for a construction permit for a medical radioisotope production facility in Columbia, Missouri. By letter dated February 5, 2015 (ADAMS Accession No. ML15086A262), NWMI withdrew and resubmitted this portion of their construction permit application PO 00000 Frm 00060 Fmt 4703 Sfmt 9990 24289 (ADAMS Accession No. ML15086A261) to include a discussion of connected actions in their environmental report in response to a letter from the NRC (ADAMS Accession No. ML14349A501). An exemption from certain requirements of 10 CFR 2.101(a)(5) granted by the Commission on October 7, 2013 (ADAMS Accession No. ML13238A333), in response to a letter from NWMI dated August 9, 2013 (ADAMS Accession No. ML13227A295), allowed for NWMI to submit its construction permit application in two parts. Specifically, the exemption allowed NWMI to submit a portion of its application for a construction permit up to 6 months prior to the remainder of the application regardless of whether or not an environmental impact statement or a supplement to an environmental impact statement is prepared during the review of its application. On February 5, 2015, in accordance with 10 CFR 2.101(a)(5), NWMI submitted the following in part one of the construction permit application: • the description and safety assessment of the site required by 10 CFR 50.34(a)(1), • the environmental report required by 10 CFR 50.30(f), • the filing fee information required by 10 CFR 50.30(e) and 10 CFR 170.21, • the general information required by 10 CFR 50.33, and • the agreement limiting access to classified information required by 10 CFR 50.37. As stated in NWMI’s February 5, 2015, letter, part two of NWMI’s application for a construction permit will contain the remainder of the preliminary safety analysis report required by 10 CFR 50.34(a) and will be submitted in accordance with the requirements of 10 CFR 2.101(a)(5). Subsequent Federal Register notices will address the acceptability of this part of the tendered construction permit application for docketing and provisions for public participation in the construction permit application review process. Dated at Rockville, Maryland, this 13th day of April, 2015. For the Nuclear Regulatory Commission. Alexander Adams, Jr., Chief, Research and Test Reactors Licensing Branch, Division of Policy and Rulemaking, Office of Nuclear Reactor Regulation. [FR Doc. 2015–10127 Filed 4–29–15; 8:45 am] BILLING CODE 7590–01–P E:\FR\FM\30APN1.SGM 30APN1

Agencies

NUCLEAR REGULATORY COMMISSION

[Federal Register Volume 80, Number 83 (Thursday, April 30, 2015)]
[Notices]
[Page 24289]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-10127]


=======================================================================
-----------------------------------------------------------------------

NUCLEAR REGULATORY COMMISSION

[Proj-0803; NRC-2013-0235]


Northwest Medical Isotopes, LLC

AGENCY: Nuclear Regulatory Commission.

ACTION: Construction permit application; receipt.

-----------------------------------------------------------------------

SUMMARY: The U.S. Nuclear Regulatory Commission (NRC) staff has 
received and is making available the first part of the application for 
a construction permit, submitted by Northwest Medical Isotopes, LLC 
(NWMI). NWMI proposes to build a medical radioisotope production 
facility located in Columbia, Missouri.

DATES: April 30, 2015.

ADDRESSES: Please refer to Docket ID NRC-2013-0235 when contacting the 
NRC about the availability of information regarding this document. You 
may obtain publicly-available information related to this document 
using any of the following methods:
     Federal Rulemaking Web site: Go to https://www.regulations.gov and search for Docket ID NRC-2013-0235. Address 
questions about NRC dockets to Carol Gallagher; telephone: 301-415-
3463; email: Carol.Gallagher@nrc.gov. For technical questions, contact 
the individual listed in the FOR FURTHER INFORMATION CONTACT section of 
this document.
     NRC's Agencywide Documents Access and Management System 
(ADAMS): You may obtain publicly-available documents online in the 
ADAMS Public Documents collection at https://www.nrc.gov/reading-rm/adams.html. To begin the search, select ``ADAMS Public Documents'' and 
then select ``Begin Web-based ADAMS Search.'' For problems with ADAMS, 
please contact the NRC's Public Document Room (PDR) reference staff at 
1-800-397-4209, 301-415-4737, or by email to pdr.resource@nrc.gov. The 
ADAMS accession number for each document referenced (if it available in 
ADAMS) is provided the first time that a document is referenced.
     NRC's PDR: You may examine and purchase copies of public 
documents at the NRC's PDR, Room O1-F21, One White Flint North, 11555 
Rockville Pike, Rockville, Maryland 20852.

FOR FURTHER INFORMATION CONTACT: Michael Balazik, Office of Nuclear 
Reactor Regulation, U.S. Nuclear Regulatory Commission, Washington, DC 
20555-0001; telephone: 301-415-2856; email: Michael.Balazik@nrc.gov.

SUPPLEMENTARY INFORMATION: On November 7, 2014, NWMI filed with the 
NRC, pursuant to Section 103 of the Atomic Energy Act of 1954, as 
amended, and part 50 of Title 10 of the Code of Federal Regulations (10 
CFR), a portion of an application for a construction permit for a 
medical radioisotope production facility in Columbia, Missouri. By 
letter dated February 5, 2015 (ADAMS Accession No. ML15086A262), NWMI 
withdrew and resubmitted this portion of their construction permit 
application (ADAMS Accession No. ML15086A261) to include a discussion 
of connected actions in their environmental report in response to a 
letter from the NRC (ADAMS Accession No. ML14349A501).
    An exemption from certain requirements of 10 CFR 2.101(a)(5) 
granted by the Commission on October 7, 2013 (ADAMS Accession No. 
ML13238A333), in response to a letter from NWMI dated August 9, 2013 
(ADAMS Accession No. ML13227A295), allowed for NWMI to submit its 
construction permit application in two parts. Specifically, the 
exemption allowed NWMI to submit a portion of its application for a 
construction permit up to 6 months prior to the remainder of the 
application regardless of whether or not an environmental impact 
statement or a supplement to an environmental impact statement is 
prepared during the review of its application. On February 5, 2015, in 
accordance with 10 CFR 2.101(a)(5), NWMI submitted the following in 
part one of the construction permit application:
     the description and safety assessment of the site required 
by 10 CFR 50.34(a)(1),
     the environmental report required by 10 CFR 50.30(f),
     the filing fee information required by 10 CFR 50.30(e) and 
10 CFR 170.21,
     the general information required by 10 CFR 50.33, and
     the agreement limiting access to classified information 
required by 10 CFR 50.37.
    As stated in NWMI's February 5, 2015, letter, part two of NWMI's 
application for a construction permit will contain the remainder of the 
preliminary safety analysis report required by 10 CFR 50.34(a) and will 
be submitted in accordance with the requirements of 10 CFR 2.101(a)(5).
    Subsequent Federal Register notices will address the acceptability 
of this part of the tendered construction permit application for 
docketing and provisions for public participation in the construction 
permit application review process.

    Dated at Rockville, Maryland, this 13th day of April, 2015.

    For the Nuclear Regulatory Commission.
Alexander Adams, Jr.,
Chief, Research and Test Reactors Licensing Branch, Division of Policy 
and Rulemaking, Office of Nuclear Reactor Regulation.
[FR Doc. 2015-10127 Filed 4-29-15; 8:45 am]
 BILLING CODE 7590-01-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.